Vaccines
Conference Coverage
Parents of patients with rheumatic disease, MIS-C strongly hesitant of COVID vaccination
A single-center study and a survey of rheumatologists revealed similar levels of hesitancy among parents of both these populations.
News from the FDA/CDC
Single bivalent COVID booster is enough for now: CDC
Booster strength wanes after a few months, spurring discussions of whether people at high risk of getting a severe case of COVID may need more...
News
Negative expectations of COVID shots may amplify side effects
It fits the psychosomatic role of “nocebo effects.”
News
Nasal COVID treatment shows early promise against multiple variants
Unlike a COVID vaccine that boosts a person’s immune system as protection, the antiviral nasal spray works more directly by blocking the virus,...
Opinion
COVID-19 vaccinations lag in youngest children
As of March 1, 2023, only 8% of children under 2 years and 10.5% of children ages 2-4 years have initiated a COVID vaccine series.
News
NOVIDs: Do some have the genes to dodge COVID?
Some in the U.S. have apparently managed to avoid the virus, data suggest.
News
Factors linked with increased VTE risk in COVID outpatients
While the overall risk for VTE was low, age of at least 55 years, being male, and having a BMI of at least 30 and history of VTE increased the...
News
Be vigilant about suspected cases of measles, expert advises
“This is a re-emerging viral infection that dermatologists must recognize,” Dr. Adelaide A. Hebert said.
Conference Coverage
Meningococcal vaccine shows benefit in STI prevention
“The duration of protective efficacy – a big thing in vaccines – is unknown. Still, this is really significant.”
News
Zika virus still calls for preparedness and vaccine development
“There’s no antiviral that you can take for Zika. Until we have a vaccine, the key to controlling/preventing Zika is controlling the mosquitoes...